HOLAA&DNCT03870360
Preventing Anxiety and Depression in Older Hispanics
StatusActive, Not Recruiting
PhaseNot applicable
SponsorUniversity of Miami
Primary completion (estimated)
At risk: Primary completion moved 7 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 22 versions: 19 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Nov 1, 2026 to Jun 1, 2027
- Eligibility criteria expanded, about 21 words
- Secondary endpoints: details revised at 1 of 4 entries
- Minor Primary and study completion dates: Jun 1, 2026 to Nov 1, 2026v21
- Minor Primary and study completion dates: Dec 1, 2026 to Jun 1, 2026v20
- Notable Primary and study completion dates: Dec 1, 2025 to Dec 1, 2026v19
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised
Show 13 earlier versionsHide 13 earlier versions
- Notable Trial status: Not Yet Recruiting to Recruiting
- Site details revised
- Notable Start date: Sep 1, 2022 to Nov 1, 2022v14
- Notable Start date: Jul 1, 2022 to Sep 1, 2022v13
- Notable Start date: May 1, 2022 to Jul 1, 2022
- Primary and study completion dates: Oct 1, 2025 to Dec 1, 2025
- Notable Start date: Feb 1, 2022 to May 1, 2022v11
- Notable Start date: Dec 1, 2021 to Feb 1, 2022
- Primary and study completion dates: Aug 1, 2025 to Oct 1, 2025
- Notable Start date: Sep 1, 2021 to Dec 1, 2021v9
- Notable Start date: Mar 1, 2021 to Sep 1, 2021v7
- Notable Start date: Dec 1, 2020 to Mar 1, 2021v6
- Notable Primary and study completion dates pushed to Aug 1, 2025
- Start date: Sep 1, 2020 to Dec 1, 2020
- Notable Start date: Mar 1, 2020 to Sep 1, 2020v4
- Minor Study description expanded, about 70 wordsv3
- Notable Start date: Sep 1, 2019 to Mar 1, 2020v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in risk factors for major depressive disorder (MDD)
Timeframe: Baseline, 16 weeks, 6, 12, 18, and 24 months
Change in risk factors for generalized anxiety disorder (GAD)
Timeframe: Baseline, 16 weeks, 6, 12, 18, and 24 months
Incidence of generalized anxiety disorder
Timeframe: 2 years
Recurrence of generalized anxiety disorder
Timeframe: 2 years
Incidence of major depression disorder
Timeframe: 2 years
Recurrence of major depression disorder
Timeframe: 2 years
Secondary (4)
Change in pro-inflammatory markers
Change in anti-inflammatory markers
Change in physical functioning as measured by the physical performance battery
Change in quality of life
Arms and interventions
HOLA: A Culturally-Tailored Health Promotion InterventionExperimental
16 week, multicomponent, health promotion intervention
Healthy lifestyles education programActive comparator
Educational material on mental health, physical activity, and information on community resources
Behavioral: HOLA Component 1, HOLA Component 2, HOLA Component 3, HOLA Component 4, Healthy lifestyles education program
Sites
1 site in 1 country
- University of MiamiMiami, Florida, United States